|CEO of South Korea's DAEYOMEDI Company came to our company to discuss cooperation in medical device projects|
|On April 12, 2018, Ms. Jiang Xiding, CEO of South Korea's DAEYOMEDI Company, and Mr. Quan Lingxiang, general manager of the company, came to our company to discuss cooperation in medical device projects. Mr. Li Luochen, the Chairman of our company, General Manager Wu Jianbin and Deputy General Manager Zhang Yunsheng received the leadership of South Korea DAEYOMEDI Company accompanied by President Wang.
The leaders of South Korea DAEYOMEDI visited and inspected the office environment of Jinkang'an Pharmaceutical Co., Ltd. and the workshop where the cooperation project was planned to be produced. They were also accompanied by Mr. Li Luochen, Chairman of the company. They consulted the relevant leaders of the Medical Device Department of Hebei Food and Drug Administration issues about landing in Hebei include research data that China and South Korea mutually recognize that meet the Chinese CFDA requirements, and differences in registration and production.
On April 13, the leaders of the two parties discussed the details of cooperation of the cooperation in the conference room of Jin Kang’an Pharmaceutical Co., Ltd. and reached an agreement. Both parties agreed to cooperate in the development of the project to provide better services for the health care of the Chinese people and share the future profits.